Skip to main content
JAGX
NASDAQ Life Sciences

Jaguar Health Secures $350K in Short-Term Notes and Warrants for Working Capital

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$0.888
Mkt Cap
$3.41M
52W Low
$0.855
52W High
$27
52W Position info
3.8% above low
Off High info
97% below high
Rel. Volume info
43× avg
Market data snapshot near publication time

JAGX is trading near its 52-week low of $0.855 (3.8% above the low) on elevated volume (43× avg).

Summary

Jaguar Health, Inc. amended a previous 8-K to correct dates related to a $350,000 unsecured promissory note and warrants for 350,000 shares, with proceeds allocated for working capital.


Key Events · Financing and Capital Events · JAGX

  • Secured Short-Term Financing

    Jaguar Health, Inc. entered into securities purchase agreements for $350,000 aggregate principal amount of unsecured promissory notes, maturing in one month.

  • Issued Warrants for Future Equity

    Investors also received warrants to purchase up to 350,000 shares of common stock at an exercise price of $1.00 per share, exercisable immediately.

  • Capital for Working Capital

    Proceeds from the notes will be used for working capital and general corporate purposes.

  • Amendment to Correct Dates

    This 8-K/A corrects scrivener's errors in the original filing regarding the execution and closing dates of the agreements, now confirmed as January 6, 2026.


Analysis · JAGX · Life Sciences

This amended 8-K clarifies the execution and closing dates of a recent financing agreement. The underlying transaction involves Jaguar Health securing $350,000 through unsecured promissory notes, which mature in a very short one-month period. Additionally, investors received warrants to purchase 350,000 shares at an exercise price of $1.00, a premium to the current stock price. While the capital infusion is crucial for working capital, the short maturity of the notes indicates immediate financial needs and could pose a refinancing challenge soon. The premium pricing of the warrants, however, suggests some investor confidence in the company's future value.

At the time of this filing, JAGX was trading at $0.89 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.4M. The 52-week trading range was $0.86 to $27.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

JAGX - Latest Insights

JAGX
Jul 27, 2026, 8:00 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.950 info
Change: -$0.0545 (-5%) info
Market Cap: $4.613M info
JAGX
Jul 27, 2026, 8:00 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.950 info
Change: -$0.0545 (-5%) info
Market Cap: $4.613M info
JAGX
Jul 24, 2026, 4:15 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.9633
Real-time Price: $0.950 info
Change: -$0.0133 (-1%) info
Market Cap: $4.613M info
JAGX
Jul 24, 2026, 1:59 PM EDT
Filing Type: S-1/A
Importance Score:
8
Price at Filing: $1.02
Real-time Price: $0.950 info
Change: -$0.0707 (-7%) info
Market Cap: $4.613M info
JAGX
Jul 15, 2026, 5:38 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $2.10
Real-time Price: $0.950 info
Change: -$1.15 (-55%) info
Market Cap: $4.613M info